Nearly a dozen healthcare research facilities are conducting studies and pilot programs that tap the use of a smartphone and a behavioral health analytic engine to improve understanding of how patient behavior affects health outcomes.
Biosciences entrepreneur Jonathan Rothberg's company Butterfly Network has raised $100 million to develop a new kind of imaging device that could see the human body in "completely new ways," according to an article in VentureBeat.
Over the next 15 years, more than 10 percent of colon cancer diagnoses, as well as almost one out of every four rectal cancer diagnoses, will be made in patients who are well below the traditional age threshold for screening, according to a new study out of the University of Texas MD Anderson Cancer Center.
New research reveals that a low-dose CT lung-screening program for an at-risk population can be cost effective, while saving lives.
One of every five American adults is using mobile technology to enhance his or her life, and the number jumps to 23 percent when it comes to those working full-time jobs, according to new Gallup research.
The use of neuroimaging can show changes in the brain resulting from vascular disease risk factors before any symptoms of cardiovascular or cerebrovascular disease occur, according to a study published in the October issue of JACC Cardiovascular Imaging.
Proton beam therapy is going through an interesting period right now.
Costs associated with proton therapy are similar to--and in some cases less than--a number of conventional radiotherapy techniques used to treat early stage breast cancer, according to research from the University of Texas MD Anderson Proton Therapy Center.
A Dartmouth professor is spearheading research focused on wearables security and developing a project, called Amulet, that would support mHealth sensing applications.
A study of the utilization rates and estimated Medicare costs of lung cancer diagnostic workups in patients who had abnormal CT scans shows that nearly half of the costs were attributed to biopsies that ultimately proved to be negative for lung cancer.